Q2 EPS Estimate for Viking Therapeutics Reduced by Analyst
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Research analysts at HC Wainwright cut their Q2 2025 EPS estimates for shares of Viking Therapeutics in a note issued to investors on Thursday, April 24th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of ($0.42) per share for the quarter, […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Research analysts at HC Wainwright cut their Q2 2025 EPS estimates for shares of Viking Therapeutics in a note issued to investors on Thursday, April 24th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of ($0.42) per share for the quarter, […]
